---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-071082"
form_type: "8-K"
ticker: "DTIL"
cik: "0001357874"
company_name: "PRECISION BIOSCIENCES INC"
filed_at: "2024-06-10T23:59:59+00:00"
generated_at: "2026-06-01T05:15:47.418177+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Precision BioSciences shareholders approve increase of 630,000 shares in incentive plan

## Summary
- Shareholders elected Stanley R. Frankel, M.D. and Samuel Wadsworth, Ph.D. as Class II directors for term until 2027.
- Ratification of Deloitte & Touche as independent auditor for FY2024 approved with 5,162,463 votes for.
- Amendment to 2019 Incentive Award Plan approved, increasing share reserve by 630,000 shares; 2,597,767 for, 836,298 against.
- Adjournment proposal approved with 2,649,161 votes for, if needed to solicit additional proxies.

## SEC filing metadata
- accession: 0000950170-24-071082
- form_type: 8-K
- ticker: DTIL
- cik: 0001357874
- company_name: PRECISION BIOSCIENCES INC
- filed_at: 2024-06-10T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357874/000095017024071082/0000950170-24-071082-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357874/000095017024071082/dtil-20240604.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-071082
- JSON: https://secwatch.observer/filing/0000950170-24-071082.json
- Plain text: https://secwatch.observer/filing/0000950170-24-071082.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.